Merck receives Australian CRISPR Nickase Patent

BioTech |  News | 0 Comment | 16 Aug, 2018

Merck, the vibrant science and technology company has announced that the Australian Patent Office has allowed the company's patent application for the use of paired CRISPR nickases. Paired ...Read more

Mundipharma brings cancer supportive care expertise to Vietnam

BioTech |  News | 0 Comment | 16 Aug, 2018

Mundipharma and Helsinn Group signed a licensing and distribution agreement for the anti-emetic agent ALOXI in Vietnam, extending an international collaboration. ALOXI (palonosetron hydroc...Read more

Macrogen receives CAP accreditation in two clinical labs in Korea

BioTech |  News | 0 Comment | 14 Aug, 2018

Macrogen, Inc., a precision medicine biotechnology company has announced that its two next generation sequencing (NGS) clinical laboratories, located in its Seoul headquarters and Bundang P...Read more

Artios Pharma announces $84 M Series B financing

BioTech |  News | 0 Comment | 13 Aug, 2018

Artios Pharma Limited (Artios), a leading DNA Damage Response (DDR) company developing innovative treatments for cancer has announced the completion of a $84 million (£65 million) Ser...Read more

Genetic Technologies Formalises Strategic Alliance with Blockchain Global

BioTech |  News | 0 Comment | 10 Aug, 2018

Genetic Technologies Limited, a diversified molecular diagnostics company embracing blockchain technologies across genomic testing platforms has announced that it has entered into a Framewo...Read more

Takeda unite Ambys to treat serious liver disease

BioTech |  News | 0 Comment | 10 Aug, 2018

Takeda has entered into a $100 million partnership with newly-launched biotech Ambys Medicines to support its discovery and development of therapies for people with serious liver disease. ...Read more

JHL Biotech Gets Positive CHMP Scientific Advice for Bevacizumab Biosimilar

BioTech |  News | 0 Comment | 10 Aug, 2018

JHL Biotech has received a positive Scientific Advice from the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) related to the EU approval pathwa...Read more

Yun Yen, MD, PhD and Winson (Sze Chun) Ho, MD Join Lixte Biotechnology’s Board of Directors

BioTech |  News | 0 Comment | 09 Aug, 2018

Lixte Biotechnology Holdings, Inc. has announced the appointments of two new members to the Board of Directors of Lixte; Yun Yen, MD, Ph.D. and Winson (Sze Chun) Ho, MD. Yun Yen, M.D. Ph.D...Read more

Biotech Firm EdiGene Raises $15 Million in Series pre-B Financing

BioTech |  News | 0 Comment | 09 Aug, 2018

EdiGene Inc., which develops genome editing technologies into novel therapeutics for a broad range of diseases and into creative solutions to advance drug discovery, today announced the suc...Read more

Genetic mutations of appendix cancer identified

BioTech |  News | 0 Comment | 09 Aug, 2018

The rarity of appendix cancer, accounting for less than 1 percent of tumors that originate in the gastrointestinal tract, and the lack of scientific data for this disease means that current...Read more

GeoVax Reports Second Quarter Financial Results

BioTech |  News | 0 Comment | 08 Aug, 2018

GeoVax Labs, Inc. a biotechnology company developing human vaccines using its novel viral vector platform technology, announced its financial results for the quarter ended June 30, 2018, an...Read more

Macrogen to Use Blockchain for Genomic Big Data

BioTech |  News | 0 Comment | 08 Aug, 2018

South-Korean biotech enterprise Macrogen, the country’s leading gene sequencing service provider, is developing a genomic big data blockchain-based platform together with a local tech...Read more

CureGenetics secures $17 M in Series A Financing

BioTech |  News | 0 Comment | 07 Aug, 2018

Cure Genetics Co., Ltd., a biotechnology company dedicated to the development of life-saving transformative medicines and molecular diagnostics using best-in-class gene editing technologies...Read more

DNAtix, Mapmygenome partner to advance personalized preventive medicine

BioTech |  News | 0 Comment | 06 Aug, 2018

Digital DNAtix Ltd., the blockchain genetics company, and Mapmygenome, a molecular diagnostics company, today announced their alliance to advance cutting-edge, personalized and preventive m...Read more

Laekna acquires exclusive rights for two oral Akt inhibitors

BioTech |  News | 0 Comment | 06 Aug, 2018

Laekna Inc., a biotechnology company headquartered in Shanghai has announced the signing of an agreement with Novartis Pharma AG for exclusive global rights to develop and commercialize two...Read more

Robert Wicke appointed as new CEO of Halo Labs

BioTech |  News | 0 Comment | 03 Aug, 2018

Halo Labs, a venture-backed scientific instrumentation company developing high-throughput biopharmaceutical quality control tools has announced the appointment of Robert Wicke as Chief Exec...Read more

Pfizer announces EC approval of its oncology biosimilar

BioTech |  News | 0 Comment | 03 Aug, 2018

Pfizer Inc. has announced that the European Commission (EC) has approved TRAZIMERA(trastuzumab), for the treatment of human epidermal growth factor (HER2) overexpressing breast cancer and H...Read more

Orchard Therapeutics Appoints Jon Ellis to Board of Directors

BioTech |  News | 0 Comment | 02 Aug, 2018

Orchard Therapeutics, a leading commercial-stage biotech company dedicated to transforming the lives of patients with rare diseases through innovative gene therapies, today announced the ap...Read more